Clinical Trial Update: Efficacy and Safety Study of Bimatoprost Sustained-Release (SR) in Participants With Open-angle Glaucoma or Ocular Hypertension [Phase 3]

View source ↗

Summary

Phase 3 trial update on the efficacy and safety of bimatoprost sustained-release (SR) for open-angle glaucoma or ocular hypertension has completed with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Bimatoprost Sustained Release (SR) (bimatoprost)

Snippet

Sponsor: Allergan | Conditions: Glaucoma, Open-Angle, Ocular Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2020-04-24